Search

Search Constraints

You searched for: Author/Creator Thomas, Debby

Search Results

3. Collecting New Peak and Intermediate Infliximab Levels to Predict Remission in Inflammatory Bowel Diseases. Issue 2 (1st February 2022)

4. Collecting New Peak and Intermediate Infliximab Levels to Predict Remission in Inflammatory Bowel Diseases. Issue 2 (30th March 2021)

5. Multi‐model averaging improves the performance of model‐guided infliximab dosing in patients with inflammatory bowel diseases. (15th June 2022)

7. Predictive models assessing the response to ustekinumab highlight the value of therapeutic drug monitoring in Crohn's disease. Issue 3 (March 2023)

8. Real-world Endoscopic and Histological Outcomes Are Correlated with Ustekinumab Exposure in Patients with Ulcerative Colitis. (9th May 2022)

9. Successful Infliximab Treatment is Associated With Reversal of Clotting Abnormalities in Inflammatory Bowel Disease Patients. Issue 9 (October 2020)

10. The effect of aging on infliximab exposure and response in patients with inflammatory bowel diseases. Issue 10 (27th March 2021)